CAR-T therapy

CD19+ CAR-T Therapy for Relapsed or Refractory B-ALL and Burkitt Lymphoma in Children and Young Adults in the Republic of Belarus
Landscape Assessment To Characterize Baseline Access And Multilevel Barriers To Improve Access To CAR-T Cell Therapy (Impact Study) Across The Euro Region